infectiousdose.bsky.social
@infectiousdose.bsky.social
First time I've seen alpha-gal syndrome in the news since we learned about it. #PITT_IDfall25
New Jersey man is first known death from meat allergy triggered by tick bites | CNN
In the summer of 2024, a previously healthy 47-year-old father collapsed and died in the bathroom of his New Jersey home. An autopsy provided no answers. Everything looked normal, and his death was ru...
www.cnn.com
November 15, 2025 at 2:31 AM
Sad story about a high schooler that died from bacterial meningitis caused by Streptococcus pneumoniae. #PITT_ID25
Pennsylvania teen dies from bacterial meningitis: School district
Ryan Duffy, 18, a senior at Neshaminy High School in Langhorne, contracted Streptococcus Pneumoniae Meningitis last week and died Tuesday.
abcnews.go.com
October 20, 2025 at 9:10 PM
"The effect of commonly used non-antibiotic medications on antimicrobial resistance development in Escherichia coli" #PITT_25
Client Challenge
www.nature.com
October 14, 2025 at 1:49 AM
Interesting case report. I don't think I've ever seen a susceptibility report with so much resistance! It is interesting that extended infusion at high doses can overcome the resistance. #PITT_ID25
Frontiers | Case Report: Management of a case of multidrug-resistant Klebsiella pneumoniae infection in a second-kidney transplant patient
This case report on recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) Klebsiella pneumoniae in a post-renal transplant patient un...
www.frontiersin.org
October 11, 2025 at 12:01 AM
Randomized pragmatic trial of the comparative effectiveness of chicken egg-based inactivated, mammalian cell-culture-based inactivated, and recombinant protein quadrivalent seasonal influenza vaccines in US Military Health System

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4pOOFmG
October 2, 2025 at 6:12 PM
Some differences between Moderna's Spikevax and mNEXSPIKE. #PITT_ID25
COVID-19 Update: mNEXSPIKE — A New Moderna mRNA Vaccine for COVID-19 | The Medical Letter Inc.
The Medical Letter has provided trusted prescription drug information and drug facts since 1959
secure.medicalletter.org
September 22, 2025 at 8:41 PM
Study from 2022-2023 influenza season indicates early oseltamivir therapy can still be effective in reducing risk of disease progression of influenza A. #PITT_ID25
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Among influenza patients hospitalized during the 2022–2023 influenza season, initiating treatment with oseltamivir on the day of admission (compared with l
academic.oup.com
September 16, 2025 at 4:45 PM
Dalbavancin was proven to be non-inferior to standard of care for Staphylococcus aureus Bacteremia in this study. However, it has some advantages such as a loading dose followed by weekly dosing vs. continuous infusions of the standard of care medications. #PITT_ID25
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia
This clinical trial compares the efficacy and safety of dalbavancin vs standard therapy for completion of treatment of complicated Staphylococcus aureus bacteremia in hospitalized patients.
jamanetwork.com
September 16, 2025 at 4:31 PM
In class we discussed the therapeutic drug monitoring that is being established for linezolid. Although the primary concern is hematologic adverse events, other events such as optic nerve disorders may also need to be considered. #PITT_ID25
September 11, 2025 at 5:29 PM
Updated guidelines for treatment of complicated UTIs was released by IDSA a few months ago. #PITT_ID25
Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management
www.idsociety.org
September 11, 2025 at 4:37 PM
We learned about the effectiveness of doxy-pep in class, but should the risk of antimicrobial resistance be more of a consideration when prescribing this regimen. #PITT_ID25
Doxycycline Post-exposure Prophylaxis and Off-target Antimicrobial Resistance: Potential Amplification Within Sexual Networks
Abstract. Doxycycline post-exposure prophylaxis is now included in many clinical guidelines, yet concerns remain regarding antimicrobial resistance, partic
academic.oup.com
September 4, 2025 at 10:54 AM